Investigation of exosome injection in combination with minoxidil in patients with androgenic hair loss
Phase 1
Recruiting
- Conditions
- Androgenetic alopecia.Androgenic alopecia, unspecifiedL64.9
- Registration Number
- IRCT20200127046282N54
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Age 18 years and above and less than 45 years
Hamilton score 2 to 5 in male and female hair loss
Complete consent of the patient to participate in the plan
Exclusion Criteria
Patients with malignancy
Receiving chemotherapy in the last 5 years
Patients with sepsis
smoking
Pregnancy or breastfeeding
Active wound or infection at the treatment site
Receiving any topical or systemic medication in the last 3 months for hair loss
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair density. Timepoint: before the start of treatment and three and six months after the start of the intervention. Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: During treatment. Method of measurement: Questionnaire and observation.;Satisfaction. Timepoint: A month after the last session. Method of measurement: Satisfaction Questionnaire and visit.;Tolerability. Timepoint: During treatment. Method of measurement: Questionnaire and visit.